DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Zabofloxacin is an investigational drug.
There have been 4 clinical trials for Zabofloxacin. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2012.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are Dong Wha Pharmaceutical Co. Ltd., Bundang CHA Hospital, and Konyang University Hospital.
There are twenty-one US patents protecting this investigational drug and one hundred and forty-eight international patents.
Recent Clinical Trials for Zabofloxacin
|Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin||Dong Wha Pharmaceutical Co. Ltd.||Phase 1|
|A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg||Ajou University||Phase 3|
|A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg||Asan Medical Center||Phase 3|
Top disease conditions for Zabofloxacin
Top clinical trial sponsors for Zabofloxacin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Zabofloxacin||Get Started Free||Hamamelitannin analogues and uses thereof||UNIVERSITEIT GENT (Ghent, BE)||Get Started Free|
|Zabofloxacin||Get Started Free||Method for using novel hydroxamic acid derivative and antibacterial substance in combination||TOYAMA CHEMICAL CO., LTD. (Shinjuku-ku, JP)||Get Started Free|
|Zabofloxacin||Get Started Free||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Get Started Free|
|Zabofloxacin||Get Started Free||Compounds and methods of treating infections||NEOCULI PTY LTD (Victoria, AU)||Get Started Free|
|Zabofloxacin||Get Started Free||Oral drug dosage forms having desired drug release profiles and uses thereof||Triastek, Inc. (Nanjing, CN)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Zabofloxacin||European Patent Office||EP3166955||2034-07-08||Get Started Free|
|Zabofloxacin||World Intellectual Property Organization (WIPO)||WO2016005340||2034-07-08||Get Started Free|
|Zabofloxacin||Australia||AU2015316400||2034-09-12||Get Started Free|
|Zabofloxacin||Brazil||BR112017004796||2034-09-12||Get Started Free|
|Zabofloxacin||Canada||CA2960936||2034-09-12||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|